FOLR1 and mesothelioma: Following the development of an FRα antibody for use on paraffin-embedded tissues (Smith et al, 2007), samples of mesothelioma have been used in this study for FRα immunohistochemistry and the results have been compared with response to treatment with pemetrexed.